164 related articles for article (PubMed ID: 18772804)
1. [Hormones and mammographic breast density].
Boisserie-Lacroix M; Lebiez-Michel N; Cavagni P; Bentolila J; Laumonier H; Bouzgarrou M; Trillaud H
J Radiol; 2008 Sep; 89(9 Pt 2):1196-203. PubMed ID: 18772804
[TBL] [Abstract][Full Text] [Related]
2. Biological significance of interventions that change breast density.
Chlebowski RT; McTiernan A
J Natl Cancer Inst; 2003 Jan; 95(1):4-5. PubMed ID: 12509389
[No Abstract] [Full Text] [Related]
3. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
5. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
7. [Breast density: a major parameter to follow during hormone replacement therapy].
Gairard B; Guldenfels C; Haehnel P; Mathelin C
Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
[TBL] [Abstract][Full Text] [Related]
8. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
[TBL] [Abstract][Full Text] [Related]
9. [Menopausal hormonal therapies: impact on mammographic breast density].
Boutet G; Boisserie-Lacroix M; Trillaud H
J Radiol; 2004 Oct; 85(10 Pt 1):1673-86. PubMed ID: 15669560
[TBL] [Abstract][Full Text] [Related]
10. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
Lyytinen H; Ylikorkala O
Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
[TBL] [Abstract][Full Text] [Related]
11. Hormones and mammographic breast density.
Warren R
Maturitas; 2004 Sep; 49(1):67-78. PubMed ID: 15351098
[TBL] [Abstract][Full Text] [Related]
12. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
14. Effect of tamoxifen on breast tissue density in premenopausal breast cancer.
Slanetz PJ; Grandpre LE; Yeh ED; Kopans DB; Mendel JB
Breast J; 2004; 10(1):27-32. PubMed ID: 14717756
[TBL] [Abstract][Full Text] [Related]
15. Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.
Conner P
Ann Med; 2007; 39(1):28-41. PubMed ID: 17364449
[TBL] [Abstract][Full Text] [Related]
16. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
Harvey JA; Pinkerton JV; Herman CR
J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
[No Abstract] [Full Text] [Related]
17. The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.
von Schoultz B
Maturitas; 2004 Sep; 49(1):S16-21. PubMed ID: 15351103
[TBL] [Abstract][Full Text] [Related]
18. Mammographic changes during postmenopausal hormonal replacement therapy with tibolone.
Pantidou A; Kaplanis K; Chrissogonidis I; Destouni C
Eur J Gynaecol Oncol; 2004; 25(4):493-4. PubMed ID: 15285312
[TBL] [Abstract][Full Text] [Related]
19. [Mammographic breast density and breast cancer risk during HRT].
Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
[TBL] [Abstract][Full Text] [Related]
20. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]